Establishment and characterization of an in vitro human small airway model (SmallAir™)

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 118, Issue , 2017, Pages 68-72

  Huang, Song ^a   Boda, Bernadett ^a   Vernaz, Jimmy ^a   Ferreira, Emilie ^a   Wiszniewski, Ludovic ^a   Constant, Samuel ^a  

^a Epithelix   (Switzerland)

Author keywords

Air liquid interface; Club cell, organotypic culture; In vitro lung model; Small airways

Indexed keywords

CLUB CELL 10 KDA PROTEIN; EPITHELIAL SODIUM CHANNEL; ISOPRENALINE; MUCIN 5AC; PROCATEROL; PROTEIN A; UNCLASSIFIED DRUG; MUC5AC PROTEIN, HUMAN; SCGB1A1 PROTEIN, HUMAN; UTEROGLOBIN;

AIRWAY; ARTICLE; BRONCHUS EPITHELIUM; CILIATED EPITHELIUM CELL; COLUMNAR EPITHELIUM; EPITHELIUM CELL; GOBLET CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MUCOCILIARY CLEARANCE; NOSE EPITHELIUM; PROTEIN EXPRESSION; TRANSEPITHELIAL RESISTANCE; WESTERN BLOTTING; ARTIFICIAL MEMBRANE; BRONCHUS; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CILIUM; CYTOLOGY; METABOLISM; PROCEDURES; RESPIRATORY MUCOSA;

BLOTTING, WESTERN; BRONCHI; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CILIA; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANES, ARTIFICIAL; MUCIN 5AC; RESPIRATORY MUCOSA; UTEROGLOBIN;

EID: 85009819796     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.12.006     Document Type: Article

References (28)

1. Allen, T.C., Pathology of small airways disease. Arch. Pathol. Lab. Med. 134:5 (2010), 702–718.
2. Burgel, P.R., et al. Small airways diseases, excluding asthma and COPD: an overview. Eur. Respir. Rev. 22:128 (2013), 131–147.
3. Martin, C., Frija, J., Burgel, P.R., Dysfunctional lung anatomy and small airways degeneration in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 8 (2013), 7–13.
4. van den Berge, M., et al. Small airway disease in asthma and COPD: clinical implications. Chest 139:2 (2011), 412–423.
5. Boers, J.E., Ambergen, A.W., Thunnissen, F.B., Number and proliferation of clara cells in normal human airway epithelium. Am. J. Respir. Crit. Care Med. 159:5 Pt 1 (1999), 1585–1591.
6. Smith, A.P., A comparison of the effects of prostaglandin E(2) and salbutamol by intravenous infusion on the airways obstruction of patients with asthma. Br. J. Clin. Pharmacol. 1:5 (1974), 399–404.
7. Chichester, C.H., et al. Characterization of the cytochrome P-450 monooxygenase system in nonciliated bronchiolar epithelial (Clara) cells isolated from mouse lung. Am. J. Respir. Cell Mol. Biol. 4:2 (1991), 179–186.
8. Devereux, T.R., Diliberto, J.J., Fouts, J.R., Cytochrome P-450 monooxygenase, epoxide hydrolase and flavin monooxygenase activities in Clara cells and alveolar type II cells isolated from rabbit. Cell Biol. Toxicol. 1:2 (1985), 57–65.
9. Allen, T.C., Small airways disease. Surg. Pathol. Clin. 3:1 (2010), 171–186.
10. Hung, C.H., et al. Regulation of TH2 responses by the pulmonary Clara cell secretory 10-kd protein. J. Allergy Clin. Immunol. 114:3 (2004), 664–670.
11. Tokita, E., et al. Club cell 10-kDa protein attenuates airway mucus hypersecretion and inflammation. Eur. Respir. J. 44:4 (2014), 1002–1010.
12. S. Huang, L. Wisniewski, S. Constant, The use of in vitro 3D cell models in drug development for respiratory diseases, in: Intech, 2011 (Drug Discovery and Development – Present and Future).
13. Huang, S., et al. Potential of in vitro reconstituted 3D human airway epithelia (MucilAir) to assess respiratory sensitizers. Toxicol. In Vitro 27:3 (2013), 1151–1156.
14. Tapparel, C., et al. Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro. Virology 446:1–2 (2013), 1–8.
15. Hogg, J.C., Macklem, P.T., Thurlbeck, W.M., Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 278:25 (1968), 1355–1360.
16. Thurlbeck, W.M., The pathology of small airways in chronic airflow limitation. Eur. J. Respir. Dis. Suppl. 121 (1982), 9–18.
17. Vikgren, J., et al. Value of air trapping in detection of small airways disease in smokers. Acta Radiol. 44:5 (2003), 517–524.
18. Sturton, G., Persson, C., Barnes, P.J., Small airways: an important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol. Sci. 29:7 (2008), 340–345.
19. Lynch, D.A., Imaging of small airways disease and chronic obstructive pulmonary disease. Clin. Chest Med. 29:1 (2008), 165–179 vii.
20. Cagle, P.T., Barrios, R., Allen, T.C., (eds.) Color Atlas and Text of Pulmonary Pathology, second ed., 2008, Lippincott Williams & Wilkins, Philadelphia, PA.
21. Wang, C.W., Muhm, J., Colby, T.V., Leslie, K.O., Small airway lesions. Diagnostic Pulmonary Pathology, second ed., 2008, Informa, New York, NY, 229–249.
22. Rock, J.R., Randell, S.H., Hogan, B.L., Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis. Model Mech. 3:9–10 (2010), 545–556.
23. Yang, Y.H., et al. Study on the risk factors regarding deep venous thrombosis in acute pulmonary thromboembolism. Zhonghua Liu Xing Bing Xue Za Zhi 29:7 (2008), 716–719.
24. Hamutcu, R., et al. Clinical findings and lung pathology in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:8 (2002), 1172–1175.
25. Baltimore, R.S., Christie, C.D., Smith, G.J., Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am. Rev. Respir. Dis. 140:6 (1989), 1650–1661.
26. Esterly, J.R., Oppenheimer, E.H., Observations in cystic fibrosis of the pancreas. 3. Pulmonary lesions. Johns Hopkins Med. J. 122:2 (1968), 94–101.
27. Benam, K.H., et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat. Methods 13:2 (2016), 151–157.
28. Schamberger, A.C., et al. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-beta. Am. J. Respir. Cell Mol. Biol. 50:6 (2014), 1040–1052.